Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma

计划入组 10 人 · 首次发布于 2005 年 8 月 3 日

LMBA02 Protocol for Patients With a Burkitt Lymphoma

计划入组 260 人 · 首次发布于 2005 年 9 月 16 日

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

计划入组 8 人 · 首次发布于 2021 年 6 月 22 日

EBV+ Lymphoma (Geneius)

MYD88 mutant lymphoma therapy

Lymphoma DNA vaccine(Genvax)

AUSTRALASIAN LEUKAEMIA & LYMPHOMA GROUP

Australia

ASSOCIATION INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP (IELSG)

Switzerland

Viridian Metals Inc

United States

Cothera Bioscience's PC-002 Receives FDA Fast Track for Burkitt Lymphoma

Xenetic Biosciences Reports DNase I Enhances CAR-T Cell Persistence and Survival in ASCO 2026 Data

Roche's Glofitamab Expands Treatment Horizons for Multiple B-Cell Lymphomas